LY 686017, a selective neurokinin 1 receptor antagonist, has demonstrated potential for alcoholism.

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1636, 2008-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A water-soluble, stable dipeptide NK 1 receptor-selective neurokinin receptor antagonist with potent in vivo pharmacological effects: S18523

By Bonnet J. Kucharczyk N. Robineau P. Lonchampt M. Dacquet C. Regoli D. Fauchere J.-L. Canet E.

European Journal of Pharmacology, Vol. 310, Iss. 1, 1996-08 ,pp. : 37-46

Elsevier

Access to resources Recommend Favorite

Microdialysis Approach to Study Serotonin Outflow in Mice Following Selective Serotonin Reuptake Inhibitors and Substance P (Neurokinin 1) Receptor Antagonist Administration: A Review

Current Drug Targets, Vol. 7, Iss. 2, 2006-02 ,pp. : 187-201

Bentham Science Publishers

Access to resources Recommend Favorite

Potential therapeutic targets for neurokinin-1 receptor antagonists

By Duffy Ruth A

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 9-21

Informa Healthcare

Access to resources Recommend Favorite

The neurokinin₁ receptor antagonist aprepitant as an antiemetic for moderately emetogenic chemotherapy

By Warr David

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. : 1653-1658

Informa Healthcare

Access to resources Recommend Favorite

Targeting Opioid and Neurokinin-1 Receptors to Treat Alcoholism

Current Medicinal Chemistry, Vol. 18, Iss. 28, 2011-10 ,pp. : 4321-4334

Bentham Science Publishers

Access to resources Recommend Favorite